Revelation Pharma Launches Nationwide Wholesale Service
The service will provide compounding pharmacy services to healthcare providers.
Stock.adobe.com
Revelation Pharma is going national with its compounding network.
The network of 503A and 503B compounding pharmacies launched a national wholesale service for healthcare providers.1 Revelation Wholesale is designed to provide users with a streamlined ordering process when purchasing compounding solutions and unique medications.
In a press release, Revelation Pharma’s national director of wholesale Shelby Owens said, “The launch of Revelation Wholesale is monumental for us and has been a true labor of love. In my over 25 years of experience, I've had the opportunity to lead some incredibly fulfilling projects, and Revelation Wholesale is one that stands out."
In the same press release, Revelation Pharma CEO Shawn Hodges added, “At Revelation Pharma, we are not just suppliers, we are collaborators, and all our work is underscored by the desire to promote well-being through the advancement in healthcare excellence. The launch of Revelation Wholesale is just another indication of our commitment, and we look forward to seeing the value it brings to providers and patients."
Revelation Pharma has made several steps this year to increase its presence across the nation. In July, the company announced that it had acquired Taylors Pharmacy and Key Compounding to expand its access in Florida and Washington state.2
In a press release issued at the time, Hodges said, “At Revelation Pharma, we aim to touch as many lives as possible through our vast range of compounding services. With the addition of Taylors Pharmacy and Key Compounding Pharmacy to the Revelation Pharma compounding network, we will further enhance that goal. We look forward to supporting both pharmacies in their dedication to their patients."
Allen Deaver, founder of Taylors Pharmacy also said, “As a pharmacy of humble beginnings, expanding our services and reaching more patients has been so fulfilling for us every step of the way. Becoming a part of the Revelation Pharma network helps us continue down that path, and we're thrilled for the opportunity."
"To join the Revelation Pharma national network of compounding pharmacies is a big step for us, especially as we look to the future in how we support our patients who have come to rely on us over the years," added HeeJoo Park, owner of Key Compounding Pharmacy. "We're excited for what's to come by this addition to the Key Compounding Pharmacy story."
In May, Revelation Pharma launched Consult RX, a nationwide service for healthcare providers and patients alike.3
At the time, Revelation Pharma VP of clinical and marketing services Tara Thompson, PharmD, FAPC, said, “The development of ConsultRX was a natural, organic move as it aligns with our commitment to delivering best-of-the-best care, which benefits patients and healthcare providers alike. Our team's passion for solving various healthcare issues in a compounding setting is our foremost priority, and we're confident ConsultRX in its consulting capabilities, will further our ability to achieve that."
Sources
- Revelation Pharma Announces Revelation Wholesale, an Extension of Its National Compounding Network. Revelation Pharma. September 17, 2024. https://www.prnewswire.com/news-releases/revelation-pharma-announces-revelation-wholesale-an-extension-of-its-national-compounding-network-302250201.html
- Revelation Pharma Announces Bi-coastal Expansion with Acquisitions of Taylors Pharmacy and Key Compounding. Revelation Pharma. July 9, 2024. Accessed September 18, 2024. https://www.prnewswire.com/news-releases/revelation-pharma-announces-bi-coastal-expansion-with-acquisitions-of-taylors-pharmacy-and-key-compounding-302192189.html
- Revelation Pharma Announces ConsultRX, a VIP Service that Elevates the Company's Commitment to Care Excellence. Revelation Pharma. May 9, 2024. Accessed September 18, 2024. https://www.prnewswire.com/news-releases/revelation-pharma-announces-consultrx-a-vip-service-that-elevates-the-companys-commitment-to-care-excellence-302141386.html
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
